Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hunan Hansen Pharmaceutical Co Ltd

+ Add to Watchlist

002412:CH

23.650 CNY 0.480 1.99%

As of 03:00:27 ET on 04/24/2015.

Snapshot for Hunan Hansen Pharmaceutical Co Ltd (002412)

Open: 23.880 Day's Range: 23.300 - 24.000 Volume: 6,033,576
Previous Close: 24.130 52wk Range: 14.000 - 26.420 1-Yr Rtn: +56.80%

Stock Chart for 002412

No chart data available.
  • 002412:CH 23.650
  • 1D
  • 1M
  • 1Y
24.130
Interactive 002412 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002412

Current P/E Ratio (ttm) 57.4727
Estimated P/E(12/2015) 42.2321
Relative P/E vs. SZASHR 1.0152
Earnings Per Share (CNY) (ttm) 0.4115
Est. EPS (CNY) (12/2015) 0.5600
Est. PEG Ratio -
Market Cap (M CNY) 7,000.40
Shares Outstanding (M) 296.00
30 Day Average Volume 7,869,920
Price/Book (mrq) 6.2530
Price/Sale (ttm) 8.9863
Dividend Indicated Gross Yield 1.06%
Cash Dividend (CNY) 0.2500
Dividend Ex-Date 05/23/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002412

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002412

Hunan Hansen Pharmaceutical Co., Ltd develops, produces and sells gastroenterologic, bone-healing, cardiovascular, and cerebrovascular Chinese medicine. The Company's products are in the form of syrup, capsule, and injection.

Liu LinganChairmanLiu ZhengqingPresident
He SanxingExec VP/Controller:FinanceLiu HouyaoVP/Secretary
More Company Profile & Key Executives for 002412

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil